MK-0873-012

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0873-012, covering 2014-02-03 to 2014-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED) [Phase 2]